Page last updated: 2024-09-05
lu 135252 and hirudin
lu 135252 has been researched along with hirudin in 1 studies
Compound Research Comparison
| Studies (lu 135252) | Trials (lu 135252) | Recent Studies (post-2010) (lu 135252) | Studies (hirudin) | Trials (hirudin) | Recent Studies (post-2010) (hirudin) |
|---|---|---|---|---|---|
| 196 | 13 | 14 | 3,658 | 378 | 995 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Ehrenreich, H; Hasselblatt, M; Jensen, N; Kamrowski-Kruck, H; Kratzin, H; Schilling, L; Sirén, AL | 1 |
Other Studies
1 other study(ies) available for lu 135252 and hirudin
| Article | Year |
|---|---|
ETA and ETB receptor antagonists synergistically increase extracellular endothelin-1 levels in primary rat astrocyte cultures.
Topics: Animals; Animals, Newborn; Astrocytes; Binding, Competitive; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Drug Synergism; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-3; Hirudins; Kinetics; Oligopeptides; Peptides, Cyclic; Phenylpropionates; Piperidines; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; RNA, Messenger; Thrombin; Transcription, Genetic | 1998 |